chrisvoncsefalvay/vaers-outcomes huggingface dataset:
SORE; CHILLS; FEVER; HEADACHE; TIRED; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's weight, height, and medical history were not reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced sore. On MAR-2021, the subject experienced chills. On MAR-2021, the subject experienced fever. On MAR-2021, the subject experienced headache. On MAR-2021, the subject experienced tired. Laboratory data included: Body temperature (NR: not provided) 101 F. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on MAR-2021, had not recovered from headache, and the outcome of chills, sore and tired was not reported. This report was non-serious.
Mom called in report of "hives" on legs and feet since this morning (vaccines given yesterday). Patient afebrile. Prescribed Benadryl 3/4 tsp QID until hives gone, plus 1 extra day.
Reactions: Injection site pain Injection site swelling Injection site redness Sever fatigue Swelling face/eyes Muscle pain - legs Muscle weakness - legs New onset hypertension Dizziness
Employee had itchiness and rash on both arms almost 30 minutes after receiving vaccine. She denied shortness if breath, tachycardia, lightheadedness, and difficulty breathing. She denies a similar reaction from any other vaccines.
syncopal episode 1 minute after receiving second Covid vaccine dose. Patient had head down and slumped over, was diaphoretic. Patient also had a syncopal episode after his first dose at the end of March, and at that time fell and hit his head, requiring a CT head.  Additionally at that time patient continued to have persistent nausea and vomiting afterwards requiring numerous antiemetics and IV fluids.  He also had a full work-up, which did not reveal any concerning signs in relation to his syncopal event.  Before syncopized today, patient denies experiencing any chest pain, palpitations, shortness of breath, nausea.  He said he began to experience some lightheadedness, and then lost consciousness.  This was witnessed by his husband, who is with the patient today.  Denies any head trauma, neck trauma.  He spontaneously regained consciousness shortly after, and felt clammy, however was not experiencing any other symptoms.  Patient currently denies any symptoms.  Endorses compliance with his medications.
Nausea; vomiting; Headache; she could not even move her head without feeling like it would fall off her body; Fever/It is off and on; This is a spontaneous report from a contactable consumer (patient). A 38-year-old female patient received the second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number unknown), via an unspecified route of administration on 24Jan2021 at a single dose for COVID-19 immunization. The patient's medical history included type 2 diabetes mellitus from 2014 and ongoing. There were no concomitant medications. The patient previously took the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) in the left arm on 03Jan2021 for COVID-19 immunization. On 24Jan2021, the patient experienced fever. It is off and on. On 25Jan2021, the patient experienced headache. Today (26Jan2021), she has had vomiting, nausea, and has still had a fever. Headache has improved. She could not even move her head yesterday (25Jan2021) without feeling like it would fall off her body. Therapeutic measures were taken as a result of the events and included treatment with paracetamol (TYLENOL), ibuprofen (ADVIL), and drank some drinks. Outcome of the fever was not recovered while of the remaining events was recovering.  Information on lot/batch number has been requested.
lymph node swollen; lower in arm only pain around shot area; Chills; This is a spontaneous report from a contactable consumer (patient). A female patient of unknown age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via unknown route of administration on 06Feb2021 in right arm at single dose for COVID-19 immunisation. Medical history and Concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 16Jan2021 for Covid-19 immunization and experienced very bad arm pain on injection arm, tiredness/fatigue, mild headache, chills, and feeling unwell. It was reported that patient experienced lower in arm only pain around shot area, lymph node swollen and sore still today and chills all in Feb2021. No treatment received for adverse events. The outcome of lymphadenopathy was not recovered, vaccination site pain was unknown, chills was recovered in Feb2021.  Information about Lot/batch number has been requested.
nothing happened when i got vaccine but with in a few weeks of getting it got bells palsy. Not even sure if its related
Diagnosed with Myocarditis after being scoped for a heart attack and having a troponin level of 16.909
Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion); Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) and POOR QUALITY PRODUCT ADMINISTERED (Patient had been administered dose while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  Reporter  states that because their facility has not been able to download the digital data logger, they have been put on hold at the moment and cannot administer the Moderna COVID-19 vaccine to patients until an assessment is made. There have been no power outages that would have impacted the Moderna vaccine. However, she reiterates that because her facility is unable to download the digital data logger, they will need to treat this issue as a temperature excursion. The data logger that caller is unable to download are for the months of DEC2021, JAN2022, and FEB2022. She says that they are filling out a temperature excursion assessment at this time. Patients have been administered doses while the temperature excursion assessment has been ongoing.  No adverse reactions were reported by any patients.  No treatment information was provided by the reporter.
Tenderness and swelling in the right armpit, beginning 1-2 days after receiving my COVID booster shot. Possibly swollen lymph nodes. The symptoms are still ongoing. No redness at the site.    Also experienced fatigue and chills for the first two days after vaccination, which has now ended.   I was asymptomatic after my first COVID dose in 04/2021 and had fatigue and chills after my second COVID dose 2 weeks after, but no lymph node swelling.  I also received an annual flu shot at the time I received my COVID booster, but have never had symptoms after a flu shot in the past.
12 hours after receiving the vaccine (historically when my vaccine side effects set in), I became lightheaded and nauseous, laid down in the floor and passed out. I came to and vomited. I was not able to get up off the floor for about 30 minutes.
redness and couple hives around injection site. c/o itching immediately after injection given. On teaspoon Benadryl given.
Patient passed out about 5 minutes after receiving second dose of Pfizer vaccine.  Symptoms include: eyes rolling, jerking movements of arms, sweating that last for 30 seconds.  Patient gained his consciousness soon after.
Sunday Nov 7th-In the morning I felt tired around 12PM. I got the chills, it got worst, had 3 blankets, head hurting, and body aching. I felt like I had the flu. Temperature 99.8. Slept for 4 hours, woke up, and still felt sick. Then slept most of the day. I could barely walk. Was too dizzy to walk. Got in the shower, felt dizzy and lightheaded in the shower, also felt faint. Went back to slept for the evening, kept tossing and turning, and drank water. No appetite but had a little soup. Monday Nov 8th- Head hurting, chills had a blanket on me. Temperature 99.2. Went to a job site at 3:20PM, felt shortness of breath so left to go home. Went home still felt lightheaded, body aches, and cold. Tuesday Nov 9th- Went to work with a sore throat, felt tired, achy and weak but no temperature. Couldn't focus and sneezed a few times. Wednesday Nov 10th- Went to work couldn't keep my eyes open, achy, and sore throat. Thursday Nov 11th-Didn't go to work. Still had lack of energy. Nov 12th, 13th, 14th -Didn't go to work. Felt better Friday.  Returned to work on Nov 15th.
Patient came in on 8/16/2007 with significant lymph adenonopathy a short time after getting MMRV and had several minor complications from getting imm, rash on face and malaize.
J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/17/2023 COVID-19 DISEASE J96.01 ACUTE HYPOXEMIC RESPIRATORY FAILURE 4/17/2023 METABOLIC ENCEPHALOPATHY
Hospitalized 12/26/21-1/28/22 to SNF, readmit for COVID- previously at a facility. PNA, dehydration, hypomagnesemia, respiratory failure
Please also refer to these case #'s as reported to MODERNA following Adverse Events: Nov. 06, 2021 - MOD 21-161817 Nov. 09, 2021 - MOD 21 - 162788 Nov. 15, 2021 - MOD 21 - 164341 Please note: The County Public Health Dept. is refusing to cooperate. #18 Approximately 15 hours after receiving the booster shot, I developed chills, shaking, tinnitus (ringing in the ears). Followed by aching, especially to the legs/knees. Severe head ache Tylenol did not relieve. Sore red arm at injection site. Brain fog and extreme fatigue continuing. Observation: two weeks out and I still "feel like garbage", not myself. (of note: I had no problems with shot #1 or #2)
Varivax vaccine administered 0.5ml SQ LA on 03/29/05. Pt self report of 10-15 chicken pox like rash has started with on blistered on 04/13/05. Possibly had fever on 4/12/05.
Submassive blood clots in lungs; other clots in lower left leg. Symptoms preceding diagnosis included heart rate spikes without activity as high as 176 bpm, high blood pressure and a sudden onset of extreme shortness of breath.
Initial report received from a healthcare professional on 08 July 2013. An 18-year-old male patient had received an intramuscular booster dose of MENACTRA (batch number: U4597AB, site of administration was not reported) on 02 July 2013. Thus the patient was administered extra dose of MENACTRA. The patient had no illness at the time of vaccination and no known allergy to the drugs. Medical conditions and concomitant medication were not reported. On an unspecified date, 5 to 6 days after vaccination, the patient experienced headache. Laboratory investigations and corrective treatment were not reported. On 08 July 2013, the patient still experienced headaches and had not recovered from the event. Documents held by sender: none.
ADMINISTRATION ERROR : Pt. received 18 micrograms of 1st Phizer dose 01/03/2022
no adverse effect; inadverently administered a dose of varivax by intramuscular injection instead of subcutaneous; This spontaneous report as received from a medical assistant refers to a patient of unknown age and gender.   No information was provided regarding the patient's medical history, concurrent conditions, previous drug reactions or concomitant medications.  On 06-SEP-2019, the patient was vaccinated with varicella virus vaccine live (oka/merck)(VARIVAX) (lot # S015459, expiry date: 20-MAY-2021) strength, dosage information and anatomical locations were unknown inadvertently administered by intramuscular injection instead of subcutaneous injection for prophylaxis (incorrect route of product administration). The outcome of incorrect route of product administration and no adverse event was unknown. No adverse effects were reported. No additional information provided.
Severe chills, muscle aches upon getting into bed.   Followed by nausea and fainting as I got out of bed at 3 in the morning . There was no fever and I haven't contacted my physician as the symptoms seem to be waning. (at close to 9AM). A slight headache accompanied all of thee symptoms.  That is also retreating.
Developed signs and symptoms of right lower leg DVT starting the day after vaccination with mild pain and becoming more prominent at the time of diagnosis 1 week later
On 01Jan2021 my jaw was also getting sore; feel what felt like a lump in her left armpit. Physically there wasn't any lump but it felt swollen and as if there was a big lump; left arm was tender to the touch/left arm get sore; major body pain/ minor aches and body sores; major headache; pain, especially in my lower back and knees; body chills; but my body pain was solely in my arm and my knees; By night time, my left arm was tender to the touch and I could not raise it very high; This is a spontaneous report from a non-contactable other health professional (patient).  A 24-years-old female patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number EL1284), via an unspecified route of administration in left arm on 30Dec2020 12:15 at single dose for COVID-19 immunization.  There were no medical history or concomitant medications. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient had no known allergies. Immediately after receiving the vaccine on 30Dec2020, the patient did not have any side effects. It wasn't until 14 hours later that the patient started to feel the effects. the patient woke up at 2 am with major body pain. the patient had a major headache and pain, especially in her lower back and knees. In addition to the pain, the patient also had body chills. The next morning the patient felt better but with minor aches and body sores. However, around 7 pm on 31Dec2020, the patient started to feel her left arm get sore. By night time, her left arm was tender to the touch and the patient could not raise it very high. the patient started getting headaches again but her body pain was solely in her arm and her knees. 01Jan2021 her jaw was also getting sore. In addition, the patient started to feel what felt like a lump in her left armpit. Physically there wasn't any lump but it felt swollen and as if there was a big lump. The feeling persisted until 03Jan2020 then it eventually went away. The outcome of felt like a lump in her left armpit was recovered on 03Jan2020 while for other events was recovered on unknown date. No treatment was received for events.   No follow-up attempts are possible. No further information is expected.
Blurred vision starting at 6:30 am 17Feb2021; This is a spontaneous report from a contactable consumer or other non-HCP (patient herself). A 44-year-old female patient received BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot Number- EM9810) via an unspecified route of administration in left arm on 15Feb2021 10:15 (at the age of 44-years-old) as dose 2, single for COVID-19 immunization. Vaccination facility type was reported as Hospital. Patient was not pregnant at the time of vaccination. Patient medical history included known allergies (hypersensitivity). The concomitant medications included levocetirizine dihydrochloride (XYZAL), melatonin, ergocalciferol (VITAMIN D). Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Historical vaccine included BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number- UNKNOWN) via an unspecified route of administration in left arm on 25Jan2021 08:30 as dose 1, single for COVID-19 immunization. The patient experienced blurred vision starting on 17Feb2021 06:30. Therapeutic measures were taken as a result of blurred vision. The adverse events resulted in emergency room/department or urgent care.  The outcome of the event was unknown.     Follow-up (12May2021): Follow-up attempts completed. No further information expected.
Urticarial rash on chest, back, urethrae, meatus, abdomen, arms, presumably an allergic rxn.
Pt came in on 12/5 w/ swelling, rash, and redness. It was hot to the touch. Pt instructed to use ice pack to relieve. Called each subsequent day and improved each day until resolution on 12/9/14.
headache; high blood pressure; administered a non-diluted version of vaccine, injected him with 6 times of the medically recommended amount of the vaccine; administered a non-diluted version of vaccine, injected him with 6 times of the medically recommended amount of the vaccine; administered a non-diluted version of vaccine, injected him with 6 times of the medically recommended amount of the vaccine; This is a spontaneous report from a contactable lawyer. A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, lot number and expiration date were not reported), via an unspecified route of administration on 22Aug2021 as dose number unknown, single for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient was administered with a non-diluted version of vaccine, injected him with 6 times of the medically recommended amount of the vaccine on 22Aug2021. As a result of improper injection, patient was hospitalized with high blood pressure, headaches, and other such extreme side effect. The reporter stated that this will hereafter be referred to as the incident. Outcome of events was unknown.  Information on the lot/batch number has been requested.
pt recv vax JUN96 & pt became pregnant in MAY97;DEC97 pt was exposed to child w/chickenpox;subsequent lab eval revealed a lack of response;
Pt stated she was very itchy around the injection site. We had a discussion before the shot about her NEOSPORIN allergy. She said she never had a problem in the past. Vaccine administered around 1 pm, patient called around 6:45 complaining of itching. Was advised to take BENADRYL and see MD if itching was not resolved.
(M|D)-Vitals: O2 98 Temp 97.5 Patient recieved COVID-19 vaccine and as soon as he got it he started feeling dizzy, turned pale and yellow and went to sit down and loss of color per (P-EMT). Right after receiving COVID-19 Vaccine given at 10:25AM. 1027 89/48 HR48 1035 110/50 HR86 1045 123/99 HR79 1048 131/82 HR73 Glucose 114 finger prick. Upon recovering at 1048 patient exam was within normal range.
This spontaneous report was received from a pharmacist refers to a 64 year old female patient without any pertinent medical history and without any concurrent conditions. On 07-AUG-2015, the patient was vaccinated with a dose of ZOSTAVAX, subcutaneous injection, 0.65mL, lot # L000461 and expiration date March 2016 (anatomical location and dose number were not reported). Concomitant therapies included LIPITOR and VAGIFEM. On 08-AUG-2015, reporter as "a day or so" after received a dose of ZOSTAVAX, the patient developed injection site erythema reported as redness and injection site pruritus reported as itching at the injection site. On 10-AUG-2015, the patient sought medical attention, she went to the pharmacy and showed the pharmacist her injection site reaction to ZOSTAVAX. The pharmacist reported that the redness at the injection site was "about the size of the palm". The patient did not receive any treatment for the adverse events and no laboratory test was performed. There was no product quality issue involved. The outcome of injection site erythema and injection site pruritus was reported as recovered on 18-AUG-2015, reported as "within 10 days of the redness developing". The reporter did not assess the relatedness of injection site erythema and injection site pruritus with ZOSTAVAX. This is one of several reports received from the same reporter. Additional information has been requested.
On my right ankle about a 4" batch of red rash. Rash is smooth and not itching.; This spontaneous case was reported by a consumer and describes the occurrence of RASH ERYTHEMATOUS (On my right ankle about a 4" batch of red rash. Rash is smooth and not itching.) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concomitant products included HYDROCODONE, FUROSEMIDE, ESCITALOPRAM, AMLODIPINE, LISINOPRIL, MIRABEGRON, OMEPRAZOLE, ERGOCALCIFEROL, EZETIMIBE and RIVAROXABAN for an unknown indication.    On 21-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 21-Jan-2021, the patient experienced RASH ERYTHEMATOUS (On my right ankle about a 4" batch of red rash. Rash is smooth and not itching.). At the time of the report, RASH ERYTHEMATOUS (On my right ankle about a 4" batch of red rash. Rash is smooth and not itching.) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.    Most recent FOLLOW-UP information incorporated above includes: On 15-Apr-2021: Event outcome updated as recovered.
Patient had Janssen COVID-19 vaccine on 5/8/21. Developed calf tightness, pain, and swelling 5/13/21. Sought medical care 5/20/21. Diagnosed with DVT 5/20/21
The first 2 shots on 3/4/2021 and 3/26/2021 were given with little or no arm pain and zero shoulder pain. This was the booster shot .Severe pain in left shoulder (not the arm) started a few days after getting the shot and continues to date. Range of motion of left shoulder is limited.
!. Beginning at 3:30 a.m. urgent need to utinate every 30-45 minutes until approx 8;30 am. (Had same response with my second dose given on 2/21/2021.)  At approx 9:00, while resting and listening to soft music, noticed a pounding in both ears and felt sporadic heart palpitation.  My sport watch indicated my heart rate at 103 (my normal rate is 60-70 bpm.  Checked heart rate and blood pressure using in-house automated equipment.  Initial BP 200/130 Pulse 103; repeated after 10 min: still 199/120, pulse 130.  I have never before had any indication of hypertension.  Usual BP is 110-130/60-70. After consulting with our resident nurse, I was transported to a nearby emergency clinic for evaluation and treatment. After a two hours at the ER, my BP was still 195/100, pulse 103.  I was administer a beta-blocker tablet  and by 3:30 pm my BP had dropped to 148/85, but my pulse rate remained above 100.